1. Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ 2006 332:1430–1434. PMID:
16777886.
2. Lee S, Moon CS, Sul D, et al. Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem 2009 42:1504–1511. PMID:
19563795.
3. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine (Phila Pa 1976) 1994 19:801–806. PMID:
8202798.
4. Ohtori S, Orita S, Yamauchi K, et al. Do physical symptoms predict the outcome of surgical fusion in patients with discogenic low back pain? Asian Spine J 2016 10:509–515. PMID:
27340531.
5. Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 2002 84:196–201. PMID:
11924650.
6. Shinohara H. Lumbar disc lesion, with special reference to the histological significance of nerve endings of the lumbar discs. Nihon Seikeigeka Gakkai Zasshi 1970 44:553–570. PMID:
5530069.
7. Sainoh T, Orita S, Miyagi M, et al. Single intradiscal administration of the tumor necrosis factor-alpha inhibitor, etanercept, for patients with discogenic low back pain. Pain Med 2016 17:40–45. PMID:
26243249.
8. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006 39:469–478. PMID:
17002866.
9. Lu XY, Ding XH, Zhong LJ, Xia H, Chen XD, Huang H. Expression and significance of VEGF and p53 in degenerate intervertebral disc tissue. Asian Pac J Trop Med 2013 6:79–81. PMID:
23317892.
10. Kim JH, Studer RK, Vo NV, Sowa GA, Kang JD. p38 MAPK inhibition selectively mitigates inflammatory mediators and VEGF production in AF cells cocultured with activated macrophage-like THP-1 cells. Osteoarthritis Cartilage 2009 17:1662–1669. PMID:
19583958.
11. Kim JH, Studer RK, Sowa GA, Vo NV, Kang JD. Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines. Spine (Phila Pa 1976) 2008 33:2253–2259. PMID:
18784630.
12. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 2002 99:11946–11950. PMID:
12181492.
13. Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol 2014 9:142–160. PMID:
24610033.
14. Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002 8:831–840. PMID:
12091877.
15. Miyagi M, Ishikawa T, Orita S, et al. Disk injury in rats produces persistent increases in pain-related neuropeptides in dorsal root ganglia and spinal cord glia but only transient increases in inflammatory mediators: pathomechanism of chronic diskogenic low back pain. Spine (Phila Pa 1976) 2011 36:2260–2266. PMID:
21228748.
16. Ohtori S, Takahashi K, Chiba T, Yamagata M, Sameda H, Moriya H. Substance P and calcitonin generelated peptide immunoreactive sensory DRG neurons innervating the lumbar facet joints in rats. Auton Neurosci 2000 86:13–17. PMID:
11269919.
17. Aoki Y, Ohtori S, Ino H, et al. Disc inflammation potentially promotes axonal regeneration of dorsal root ganglion neurons innervating lumbar intervertebral disc in rats. Spine (Phila Pa 1976) 2004 29:2621–2626. PMID:
15564910.
18. Ng EW, Adamis AP. Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases. Ann N Y Acad Sci 2006 1082:151–171. PMID:
17145936.